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ScienceDirectTo preserve fitness in unpredictable, fluctuating environments,
a range of biological systems probabilistically generate variant
phenotypes — a process often referred to as ‘bet-hedging’,
after the financial practice of diversifying assets to minimize risk
in volatile markets. The molecular mechanisms enabling bet-
hedging have remained elusive. Here, we review how HIV
makes a bet-hedging decision between active replication and
proviral latency, a long-lived dormant state that is the chief
barrier to an HIV cure. The discovery of a virus-encoded bet-
hedging circuit in HIV revealed an ancient evolutionary role for
latency and identified core regulatory principles, such as
feedback and stochastic ‘noise’, that enable cell-fate
decisions. These core principles were later extended to fate
selection in stem cells and cancer, exposed new therapeutic
targets for HIV, and led to a potentially broad strategy of using
‘noise modulation’ to redirect cell fate.
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Introduction: ‘bet-hedging’ during fate-
selection decisions
Biological systems use two general strategies to maintain
fitness in variable, fluctuating environments. One strategy
involves the evolution of sophisticated sensor-actuator
networks that continually assess environmental surround-
ings and adapt, generating a tailored response to a given
surrounding. Sensor-actuator strategies appear through-
out bacterial chemotaxis systems and osmoregulation [1–
5]. An alternate strategy, proposed 50 years ago by the
theoretical ecologist Dan Cohen [6], involves probabilis-
tically generating a range of different phenotypes in any
given environment. While studying desert annual plants,
where reproductive success is governed by unpredictable
weather patterns, Cohen noted that fitness could be
enhanced if seeds varied in their germination potential,www.sciencedirect.com allowing chance to govern each seed’s fate to germinate or
not. For example, if husk thickness of each seed is
allowed to stochastically vary, a fraction of seeds will
randomly remain non-germinated regardless of the envi-
ronment, leaving a long-lived sub-population to avoid
extinction during long-term droughts. Borrowing from
economic theory, Cohen proposed that biological organ-
isms could ‘hedge their bets’ in much the same way that
financial houses diversify their assets — between higher-
risk (higher-yield) stocks and lower-risk (lower-yield)
securities — in order to minimize risk against market
crashes.
Stochastic gene expression enables ‘bet-
hedging’: from theory to the initial HIV
evidence
For many years, the molecular mechanisms enabling
biological systems to probabilistically hedge their bets
between alternate developmental fates remained unclear.
Viruses proved to be powerful model systems to define
core regulatory principles underlying bet-hedging deci-
sions. Viruses optimize fitness in variant cellular environ-
ments (i.e., target rich vs. target poor) and do so under
strong genetic constraints, selecting for minimalist regu-
latory circuits (RNA virus genomes are typically 10 kB,
thereby precluding sophisticated environmental sensing
and actuation that require multiple genes and substantial
genomic real estate). In the late 1990s, mathematical
models of the lysis-lysogeny fate decision in the bacterial
virus phage l suggested that a basic biophysical phenom-
enon intrinsic to life at the single-cell level — molecular
fluctuations driven by Brownian diffusion — could gen-
erate the variability required for a developmental bet-
hedging decision [7]. These diffusion-driven Brownian
fluctuations in regulatory enzymes, mRNAs, and other
biomolecules are unavoidable and appear sufficient to
shift cells between transcriptional on and off states [8].
With some cells randomly active and others dormant, the
computational result is a distribution of cell fates across a
population. That is, the models showed that stochastic
fluctuations in gene expression enable the phage to
mediate between its two alternate developmental fates
without sensor-actuator circuitry.
The first experimental evidence for the theory that mo-
lecular fluctuations could drive a developmental bet-
hedging decision was found in another virus: the human
immunodeficiency virus type 1 (HIV), which
probabilistically chooses between active transcription
and a latent state [9]. HIV has become a useful model
to experimentally elucidate core principles underlying
stochastic bet-hedging, and the principles discovered inCurrent Opinion in Cell Biology 2015, 37:111–118
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occurring in bacteria [10], stem-cell reprogramming
[11,12], and cancer drug tolerance [13]. Below, these core
principles of fate-selection are reviewed in the context of
the HIV latency decision.
HIV latency: a bet-hedging strategy to
optimize viral transmission
Upon infecting CD4+T lymphocytes, HIV either actively
replicates to rapidly produce progeny virions or enters a
long-lived quiescent state (proviral latency), from which it
subsequently reactivates [14]. Latently infected cells
form a viral reservoir, enabling life-long viral persistence
and necessitating lifelong antiretroviral therapy (ART) for
HIV-infected individuals. The evolutionary conundrum
was how latency had been maintained over the centuries
of natural lentiviral infections in non-human primates
before the current ART era, given the rapid evolution
of the virus.
Historically, the prevailing dogma in retrovirology had
been that HIV latency played no role during HIV’s
natural history of infection [14,15]. In the absence of
ART, latency was thought to be a deleterious phenotype,
since latently infected cells produce no virus and decrease
viral loads. Given latency’s reduction of lentiviral repli-
cative fitness, latency seemed to be an evolutionary
accident — an ‘epiphenomenon’ reflecting serendipitous
lentiviral infection of some CD4+ T cells precisely during
their transition from an activated state to a quiescent-
memory state [16–18]. Latency was therefore viewed as
an infrequent bystander effect that occurs only after a
virus-driven adaptive immune response begins and CD4+
T lymphocytes start to form memory subsets.
However, several findings were inconsistent with this
dogma. First, in Rhesus monkeys, viral latency is rapidly
established long before the adaptive immune response
begins [19]. Second, in patient cells, reactivation of
quiescent-memory cells infected with latent HIV did
not necessarily reactivate the latent virus [20,21]. Third,
latency occurs with high frequency in cell culture (50%
of infected cells establish latency), despite the absence of
immune responses or any cellular relaxation to memory
[22,23]. Fourth, remarkably, HIV’s Tat feedback circuit
is sufficient to generate a probabilistic bet-hedging deci-
sion in the absence of cellular relaxation, and the molec-
ular architecture of the circuit appears optimized to
generate a bet-hedging decision [9,24,25] (described in
more detail below).
If latency were a non-beneficial viral trait or an epiphe-
nomenon, the latency phenotype should have been lost
due to natural selection or genetic drift — given the rapid
evolution of lentiviruses — and the viral gene-regulatory
circuitry should have evolved away from being an
intrinsic latency generator. The persistence of thisCurrent Opinion in Cell Biology 2015, 37:111–118 virus-encoded latency circuit suggested an unknown
selective advantage that counterbalances latency’s puta-
tive fitness cost (i.e., reduced long-term viral loads).
To address this discrepancy, Rouzine et al. [26] exam-
ined whether latency could provide a fitness advantage
during initial infection, when the virus must pass through
the target-cell-poor mucosa, where >90% of HIV infec-
tions start [27]; the evolutionary precursor to HIV in
humans — SIV in non-human primates — also spreads
through mucosal transmission [28]. In target-poor envir-
onments (e.g., the early mucosa) high virulence quickly
depletes available targets, leaving no infectable cells at
the site. Consequently, if a virus is highly virulent, the
mucosal infection is extinguished before the virus can
spread to the target-rich environments to generate self-
sustaining systemic infection (Figure 1). In fact, direct
observations in macaques show that mucosal infections
precipitously decay toward local extinction in the first few
days after inoculation [27,29].
Rouzine et al. [26] built off patient-validated models
[30] to calculate what the optimum bet-hedging frequen-
cy would be, given the inherent cost–benefit tradeoff
latency generates between systemic and mucosal infec-
tion. Surprisingly, they found the optimal bet-hedging
frequency was 50% latency, the same latency frequency
typically found in infections of cultured T lymphocytes.
Incorporating immune responses into the model enabled
the authors to fit all available patient data, including a far
lower latency frequency [26]. A recent clinical study in
patients [31] further supports the model that latency is a
bet-hedging adaptation to optimize transmission through
the target-poor mucosa.
Molecular architecture of HIV’s bet-hedging
circuit
For many years, the absence of a viable evolutionary
fitness argument bolstered the notion that HIV proviral
latency was a bystander effect (i.e., epiphenomenon)
ineludibly resulting from transcriptional silencing during
relaxation of activated lymphocytes to a quiescent-mem-
ory state (Figure 2a). However, despite the vast literature
of associative evidence linking latent HIV integration
sites to silenced chromatin and correlating latency with
cellular silencing [32,33], there was also evidence for an
alternate model where latency was controlled by viral
gene-regulatory circuitry [9,20,34] without strict depen-
dence on cellular state (Figure 2a). Critically, the hypoth-
esis that latency establishment was driven by cellular
state had never been directly tested (i.e., lymphocytes
had never been infected and tracked in real time as they
underwent relaxation to memory).
The first direct test between these models was only
recently carried out. Razooky and Pai et al. [35]
isolated primary CD4+ T lymphocytes from humanwww.sciencedirect.com
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HIV latency: a bet-hedging strategy to optimize viral transmission. (a)
Upon infecting CD4+ T lymphocytes, HIV can either actively replicate and
rapidly destroy the cell or enter a long-lived quiescent state (proviral
latency), from which it can subsequently reactivate. The reservoir of latent
cells precludes curative therapy. (b) The evolutionary role of latency;
schematic of two competing HIV strains during early infection — a
hypothetical latency-incapable strain (upper) and the extant latency-
capable strain (lower). Infection begins with viral inoculation in the mucosa
and progresses — in some cases — to systemic infection in the lymphoid
tissue, where >98% of CD4+ T cells reside [48]. An HIV strain incapable
of entering latency would generate increased viral loads during systemic
infection, transferring more virions to new hosts. However, the latency-
incapable virus would rapidly destroy the small CD4+ T cell population
initially present in the mucosa of the new host — reducing the probability
of systemic infection. In contrast, an HIV strain capable of probabilistically
entering latency (i.e., bet hedging) would generate lower viral loads during
target-rich systemic infection, transferring fewer virions to new hosts, yet,
the relatively few transferred virions would not destroy all mucosal target
cells. By entering long-lived latency in some mucosal cells, the latency-
capable strain increases its probability of surviving initial infection to
establish systemic infection. Calculations of the optimal bet-hedging
frequency for latency to constitute an evolutionary stable strategy match
observed frequencies of latency in cell culture [26].
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HIV latency establishment is largely autonomous to cellular relaxation. (a)
Two models of HIV latency regulation. The ‘epiphenomenon’ hypothesis
of HIV latency regulation (left) predicted a strong correlation between
cellular activation state and viral activity: as CD4+ T cells relaxed from an
activated state (permissive to infection) to a resting-memory state, they
would silence HIV gene expression to drive latency establishment. The
alternate hypothesis (right) held that Tat positive-feedback circuitry is
sufficient to enable probabilistic bet hedging and that viral gene
expression is robust to changes in the cell state. This autonomous circuit
hypothesis predicts that cellular relaxation does not necessarily drive
establishment of latency and that both latent and active viral expression
can occur irrespective of cellular state. (b) Schematic of experiment to
directly test cellular dependence of latency versus autonomous viral
programming of latency. CD4+ T cells, derived from human donors, were
activated to enable HIV infection, infected with a single-round HIV (env-
deleted and expressing a short-lived GFP), and cells were then allowed to
relax to resting memory (by removal of activation stimuli). HIV expression
and cellular activation levels were tracked for two weeks by flow
cytometry. (c) Transitioning of primary T lymphocytes from activated to
resting did not silence HIV expression as assayed by flow cytometry
analysis of CD25/CD69 cell-activation markers and viral GFP expression.
Although cells fully relax from activated to resting, viral gene expression
does not silence (even despite extension of infected-cell lifetime due env
deletion). Data shown from duplicate infections performed on cells from
two donors (adapted from [35]).
www.sciencedirect.com Current Opinion in Cell Biology 2015, 37:111–118
114 Differentiation and diseasedonors, activated the cells to enable HIV infection, and
infected them with a single-round HIV (env-deleted)
expressing a short-lived green fluorescent protein
(GFP) (Figure 2b). The activated cells were then allowed
to relax to resting memory (by removing activationFigure 3
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IV fate-selection circuit. The HIV LTR promoter fluctuates between a
etent (OFF) state [36,38]. In the ON state, Tat protein, can
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ic simulations of this minimal circuit show that molecular fluctuations
 will fluctuate to zero in some cells (i.e., trajectories) but not in other
 that a minimal LTR-Tat-GFP feedback circuit is sufficient to generate
ositive feedback eliminates the phenotypic bifurcation both
uit (left) validates model predictions that the minimal Tat positive-
ddle) and for HIV resilience to cellular silencing (right). The FKBP
ack), but the small molecule Shield-1 inhibits FKBP-mediated
ositive feedback loop. Cellular relaxation experiment performed as in
eedback was chemically modulated using Shield-1 [35].
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The HIV latency circuit Weinberger 115resilient to cellular state and pointing to an intrinsic viral
program controlling the establishment of latency.
To determine the mechanisms that might comprise the
viral program, mathematical modeling of the HIV circuit
was used to define the minimal core principles that could
enable a fate-selection decision and allow the fate deci-
sion to be resilient to cellular relaxation. Previous single-
cell studies had determined that HIV’s long-terminal
repeat (LTR) promoter, the virus’s only promoter, is
exceptionally noisy [36]; the dominant noise source is
large, infrequent ‘bursts’ of transcription [37,38] such that
the promoter can be modeled using a two-state ‘random
telegraph’ model [38]. It was also known that LTR noise
is amplified by positive feedback from HIV’s Tat protein,
which transactivates the LTR [39]. Thus, the viral circuit
can be modeled as a two-state promoter with positive
feedback (Figure 3a). Stochastic simulations of this mini-
mal Tat-feedback circuit recapitulated a phenotypic bi-
furcation between a transcriptionally active and latent
state (Figure 3b), which matched the original experimen-
tal observation [9] that a minimal Tat positive-feedback
circuit is sufficient to generate a phenotypic bifurcation in
genetically identical cells (Figure 3c). Importantly, the
simulations showed that the bifurcation can occur largely
independent of cell state [35].
To experimentally test the mathematical model that Tat
circuitry by itself can establish HIV latency independent
of cellular state, a synthetic biology approach was used
[35]. A minimal synthetic Tat-feedback circuit was
constructed that allowed tuning of feedback strength
through chemically modulated proteolysis (Figure 3d).
Then, the primary-cell cellular-relaxation experiment
was repeated to determine if the minimal Tat circuit
was resilient to cellular silencing, as was the full-length
virus. As predicted, when Tat feedback was abrogated —
by rapid proteolysis of Tat — HIV transcription was
silenced as the cells became quiescent. But, when Tat
proteolysis was chemically blocked by a small molecule
(Shield-1), Tat feedback alone was sufficient to overcome
the cellular silencing during relaxation to quiescence in
the primary T cells (Figure 3d). The results demonstrate
that Tat feedback is necessary and sufficient to establish
HIV latency independent of cellular silencing.
How does HIV achieve this paradoxical functioning?
Specifically, how is HIV simultaneously resistant to the
global effects of cellular silencing while sensitive enough
to molecular fluctuations to allow these to drive transcrip-
tional switching?
The regulatory circuit architecture provides a mecha-
nism. Although the LTR responds to external stimuli,
the response is relatively small — strong transcriptional
activators (e.g., TNF, which induces changes in NFkB)
generate only 2-fold changes in LTR expressionwww.sciencedirect.com [9,24,40]. In contrast, Tat transactivation increases
LTR expression by >50-fold. This strong positive feed-
back from Tat transactivation effectively insulates the
circuit from the relatively weak effects of cell-state
changes and other external stimuli. The only mechanisms
that can significantly influence the activated circuit are
those that disrupt feedback, such as the large stochastic
bursts that are intrinsic to LTR expression and that are
amplified by Tat feedback. The resulting Tat fluctua-
tions can be so extreme that Tat molecules are complete-
ly depleted, which is sufficient to drive probabilistic
switching to an off state [24,40]. Essentially, during a
large fluctuation the system can fluctuate into zero Tat
molecules, which constitutes a ‘molecular extinction’,
from which there is no recovery; this is analogous to a
self-replicating system (e.g. bacterial division) where a
fluctuation to a population size of zero results in extinc-
tion. For the HIV circuit, transcriptional elongation from
the LTR promoter is so weak in many integration sites
that the circuit approximates a self-replicating system:
Tat can only be produced when Tat is present to trans-
activate the LTR. Overall, positive feedback is the core
mechanism that enables the circuit to be flipped by
stochastic transcriptional fluctuations even when deter-
ministic processes are unable to flip the switch [35].
Two functional aspects of the circuit are worth highlight-
ing from an evolutionary perspective. First, comparable
positive-feedback architecture had been proposed on
theoretical grounds to be an unreliable environmental
sensor in fluctuating environments [43]. Thus, HIV’s
circuit architecture is precisely the opposite of what
would be expected for an environmental sensor that
would respond reliably to cellular changes. Second,
high-magnitude noise, as exhibited by the LTR, is gen-
erally deleterious, being selected against and filtered out
of regulatory circuits [41,42]. So, the high level of noise in
HIV circuitry is extraordinary given the virus’s rapid
evolutionary rate, supporting the concept that expression
noise is selectively beneficial for HIV’s fate decision.
Hence, viral evolution appears to have selected for cir-
cuitry that both maintains strong autonomy from envi-
ronmental cues and simultaneously drives probabilistic
on-off decisions.
Conclusion: bet-hedging circuits as targets
for therapy
Stochastic noise is now considered a fundamental process
driving diverse cell-fate decisions [11–13] and is recog-
nized as a primary clinical barrier to reversing latency in
patients (i.e., curing HIV) [21,44,45]. Decoding of the core
fate-selection circuit in HIV recently led to development
of several new therapeutic avenues.
On the one hand, newly designed Tat-feedback inhibi-
tors block latent reactivation in patient samples [46],
demonstrating the critical role of the Tat circuit in laten-Current Opinion in Cell Biology 2015, 37:111–118
116 Differentiation and disease
Figure 4
(a)
(b)
(c)
PM
A
 o
nl
y
V1
2
V1
3
V1
4
V1
1 V4 V9 V6 V5 V3 V1 V2 V1
0 V7
Noise Enhancers
%
 R
ea
ct
iv
at
io
n
0
10
60
70
80
90
100
–PMA
+PMA
Reactivation
Synergy
No
Reactivation
Synergy
Chemical Potential Epigenetic Landscape
Noise
Enhancer
Activator
Catalyst
Bunsen
Burner
Latent Active
d2GFP
LTR Noise
Enhancers
(85)
Untreated
TNF, PMA
–0.5
0
0.5
1.0
1.5
2.0
2.5
Δ 
N
oi
se
–2 –1 0 1 2
Log2(GFP Treated/GFP Untreated)
GFP
# 
Ce
lls
Activator
Noise
Enhancer
GFP
Current Opinion in Cell Biology
Controlling bet-hedging circuitry through noise modulation. (a) Conceptual basis for noise modulation. Left: chemical-reaction efficiency is
enhanced not only by catalysts but also by increasing the thermal energy (i.e., kT in the Arrhenius equation). Although catalysts deterministically
lower activation-energy barriers on potential-energy landscapes, amplifying thermal fluctuations (e.g., via a Bunsen burner) provides an added
perturbation for crossing activation-energy barriers. Right: On a Waddington epigenetic landscape, small-molecule enhancement of stochastic
gene-expression fluctuations is analogous to increasing thermal fluctuations in chemical systems. (b) Identification of small molecules that
enhance noise in HIV gene expression. Left: LTR-GFP construct and schematic histograms of cells exposed to either a transcriptional activator or
a noise enhancer. Right: Each point represents flow cytometry analysis of 50 000 LTR-GFP-expressing cells exposed to a compound;
85 transcriptional noise enhancers identified from among 1600 FDA-approved drugs (red) are shown as in [47]; the effect of TNF or PMA
(activators) is shown in blue. (c) Noise-enhancer molecules (labeled V12, V13, among others) synergize with conventional activators such as PMA
(blue) and significantly modulate HIV’s fate decision by enhancing (purple) reactivation of latent HIV in donor-derived human primary T cells [47].
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foundation for an orthogonal approach of enhancing gene-
expression noise to reactivate and kill latently infected cells
(Figure 4a). This strategy [47] has potential to direct cell-
fate across a broad class of biological systems and is concep-
tually similar to approaches in physical and chemical sys-
tems where fluctuations are amplified to drive a system over
a barrier. Indeed Dar et al. identified [47] a set of FDA-
approved small molecules that modulate noise in LTR
expression without altering the mean level of LTR expres-
sion (Figure 4b). Strikingly, these noise-modulating com-
pounds — which would be overlooked in conventional
screens — synergized with conventional transcriptional
activators and increased reactivation of latent HIV
(Figure 4c). As FDA-approved compounds, noise enhancers
have potential therapeutic application to HIV and possibly
other clinically relevant cell-fate decisions [11–13].
In conclusion, noise-driven cell-fate decisions are likely a
primitive biological phenomenon and it appears possible
to exploit the underlying noise as a clinical tool to reverse
microbial persistence and potentially reprogram cell fate
in general.
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